#BEGIN_DRUGCARD DB02174

# AHFS_Codes:
Not Available

# ATC_Codes:
A16AA03

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
5959-95-5

# ChEBI_ID:
17061

# Chemical_Formula:
C5H10N2O3

# Chemical_IUPAC_Name:
(2S)-2-amino-4-carbamoylbutanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from glutamic acid and ammonia. It is the principal carrier of nitrogen in the body and is an important energy source for many cells. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
D-Glutamine

# HET_ID:
DGN

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1

# InChI_Key:
InChIKey=ZDXPYRJPNDTMRX-VKHMYHEASA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00819

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2174

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
146.1445

# Molecular_Weight_Mono:
146.069142196

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1B74

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-3.3

# Predicted_LogS:
-0.17

# Predicted_Water_Solubility:
9.78e+01 g/l

# Primary_Accession_No:
DB02174

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5961

# PubChem_Substance_ID:
46508385

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01181

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CCC(N)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
D-2-Aminoglutaramic acid

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:52 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AF212972

# Drug_Target_1_GenBank_ID_Protein:
6707573

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
murI

# Drug_Target_1_Gene_Sequence:
>765 bp
ATGAAGATAGGTATCTTTGACAGTGGTGTGGGGGGACTTACTGTTCTAAAGGCTATAAGA
AATAGATACAGAAAGGTTGATATAGTATACCTCGGTGATACCGCAAGGGTTCCCTACGGC
ATAAGGTCTAAAGATACGATAATCAGATACTCCCTTGAGTGTGCGGGCTTTTTAAAGGAT
AAGGGTGTTGATATAATCGTCGTTGCCTGCAATACCGCAAGTGCTTACGCTCTTGAACGT
TTAAAGAAAGAGATAAACGTTCCCGTTTTCGGCGTTATTGAACCCGGGGTTAAAGAAGCC
TTAAAAAAGTCAAGGAATAAAAAAATAGGAGTTATAGGAACTCCTGCAACCGTAAAAAGC
GGAGCCTACCAGAGAAAGCTTGAAGAGGGGGGAGCTGATGTTTTTGCAAAGGCCTGTCCC
CTATTCGTTCCCCTTGCGGAGGAAGGTCTCCTTGAGGGGGAGATAACAAGAAAGGTTGTA
GAACACTACCTTAAGGAGTTTAAAGGTAAGATTGATACTCTGATTTTAGGATGTACCCAT
TACCCCCTTCTTAAAAAGGAGATAAAGAAGTTTTTGGGAGACGTTGAAGTCGTTGACTCT
TCCGAAGCCCTTTCCCTTTCCCTCCATAACTTTATAAAGGACGATGGGTCCTCATCCCTT
GAGTTATTTTTTACGGACCTTTCCCCAAATCTCCAGTTTTTGATTAAATTAATACTCGGT
AGGGATTACCCGGTAAAACTTGCGGAGGGGGTTTTTACACATTAA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
10331867	Hwang KY, Cho CS, Kim SS, Sung HC, Yu YG, Cho Y: Structure and mechanism of glutamate racemase from Aquifex pyrophilus. Nat Struct Biol. 1999 May;6(5):422-6.
10484173	Kim SS, Choi IG, Kim SH, Yu YG: Molecular cloning, expression, and characterization of a thermostable glutamate racemase from a hyperthermophilic bacterium, Aquifex pyrophilus. Extremophiles. 1999 Aug;3(3):175-83.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2662

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
27993

# Drug_Target_1_Name:
Glutamate racemase

# Drug_Target_1_Number_of_Residues:
254

# Drug_Target_1_PDB_ID:
1B74

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01177	Asp_Glu_race

# Drug_Target_1_Protein_Sequence:
>Glutamate racemase
MKIGIFDSGVGGLTVLKAIRNRYRKVDIVYLGDTARVPYGIRSKDTIIRYSLECAGFLKD
KGVDIIVVACNTASAYALERLKKEINVPVFGVIEPGVKEALKKSRNKKIGVIGTPATVKS
GAYQRKLEEGGADVFAKACPLFVPLAEEGLLEGEITRKVVEHYLKEFKGKIDTLILGCTH
YPLLKKEIKKFLGDVEVVDSSEALSLSLHNFIKDDGSSSLELFFTDLSPNLQFLIKLILG
RDYPVKLAEGVFTH

# Drug_Target_1_Reaction:
L-glutamate = D-glutamate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Provides the (R)-glutamate required for cell wall biosynthesis. Converts L- or D-glutamate to D- or L-glutamate, respectively, but not other amino acids such as alanine, aspartate, and glutamine

# Drug_Target_1_SwissProt_ID:
P56868

# Drug_Target_1_SwissProt_Name:
MURI_AQUPY

# Drug_Target_1_Synonyms:
EC 5.1.1.3

# Drug_Target_1_Theoretical_pI:
9.24

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02174
